Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Nasdaq Clean Edge Global Water UCITS ETF 23.07.2026 H2O LN IE000Q8F0M81  600,002.00 USD  12,047,159.06   20.079  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Income UCITS ETF 23.07.2026 UINC IE00BZBW4Z27 10,312,146.00 USD 414,336,785.96   40.179  ...

HOUSTON--(BUSINESS WIRE)--HPE (NYSE: HPE) today announced the appointment of David Goulden to its Board of Directors, effective today. Goulden joins the Board’s Finance & Investment Committee and HR & Compensation Committee. Goulden brings more than 35 years of experience, including extensive management and financial leadership at global technology companies. Most recently, he served as Executive Vice President and Chief Financial Officer of Booking Holdings Inc., the global online trav...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Max Buffer UCITS ETF - September 23.07.2026 MSEP.LN IE0009DRFET8   50,002.00 USD   1,396,449.17   27.928  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Rising Dividend Achievers UCITS ETF 23.07.2026 RDVY LN IE000K5F6EL4  925,002.00 USD  23,421,627.94   25.321  ...

OAKVILLE, Ontario--(BUSINESS WIRE)--Groupe de portefeuilles Harvest Inc. (« Harvest ») déclare la distribution mensuelle en espèces payable Société à capital scindé Grandes pharmaceutiques de 0,1031 $ pour chaque action de catégorie A (PRM:TSX) pour le mois se terminant le 31 juillet 2026. La distribution est payable le 6 août 2026 aux actionnaires de catégorie A inscrits à la clôture d'activité au 31 juillet 2026. Pour plus d'informations : veuillez visiter www.harvestportfolios.com, envoyer u...

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the second quarter ended June 30, 2026. The Company's financial and operating results, as well as its updated guidance and key assumptions, are consistent with its July 14, 2026 second quarter preview. Key second quarter metrics (all percentage changes compare 2Q 2026 to 2Q 2025 unless otherwise noted): Revenues increased 8.7 percent to $20.230 billion Net income attributable...